Abstract
In the nuclei of hepatocytes, glucokinase regulatory protein (GKRP) modulates the activity of glucokinase (GK), a key regulator of glucose homeostasis. Currently, direct activators of GK (GKAs) are in development for the treatment of type 2 diabetes. However, this approach is generally associated with a risk of hypoglycemia. To mitigate such risk, we target the GKRP regulation, which indirectly restores GK activity. Here we describe a screening strategy to look specifically for GKRP modulators, in addition to traditional GKAs. Two high-throughput screening campaigns were performed with our compound libraries using a luminescence assay format, one with GK alone and the other with a GK/GKRP complex in the presence of sorbitol-6-phosphate (S6P). By a subtraction method in the hit triage process of these campaigns, we discovered two close analogs that bind GKRP specifically with sub-μM potency to a site distinct from where fructose-1-phosphate binds. These small molecules are first-in-class allosteric modulators of the GK/GKRP interaction and are fully active even in the presence of S6P. Activation of GK by this particular mechanism, without altering the enzymatic profile, represents a novel pharmacologic modality of intervention in the GK/GKRP pathway. © 2014 Society for Laboratory Automation and Screening.
Author supplied keywords
Cite
CITATION STYLE
Chen, K., Michelsen, K., Kurzeja, R. J. M., Han, J., Vazir, M., St. Jean, D. J., … Wahl, R. C. (2014). Discovery of small-molecule glucokinase regulatory protein modulators that restore glucokinase activity. Journal of Biomolecular Screening. SAGE Publications Inc. https://doi.org/10.1177/1087057114530468
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.